Terms: = Lung cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP
89 results:
1. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract] [Full Text] [Related]
2. Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).
Chandnani N; Mandal A; Gupta I; Mukherjee O; Rakshit S; Shanmugam G; George M; Sarkar K
Med Oncol; 2023 Dec; 41(1):28. PubMed ID: 38146020
[TBL] [Abstract] [Full Text] [Related]
3. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
4. Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.
Mander ES; Merrick CB; Nicholson HA; Lord HK; Ferguson MJ; Smith G
BMJ Open; 2023 Nov; 13(11):e076715. PubMed ID: 37989364
[TBL] [Abstract] [Full Text] [Related]
5. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
Hendrick RE; Smith RA
Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
[TBL] [Abstract] [Full Text] [Related]
6. Modelled mortality benefits of multi-cancer early detection screening in England.
Sasieni P; Smittenaar R; Hubbell E; Broggio J; Neal RD; Swanton C
Br J Cancer; 2023 Jul; 129(1):72-80. PubMed ID: 37185463
[TBL] [Abstract] [Full Text] [Related]
7. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, pax5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract] [Full Text] [Related]
8. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ; Kurtz DM; Alig SK; Frank MJ; Shukla N; Garofalo A; Macaulay CW; Shahrokh Esfahani M; Olsen MN; Hamilton J; Hosoya H; Hamilton M; Spiegel JY; Baird JH; Sugio T; Carleton M; Craig AFM; Younes SF; Sahaf B; Sheybani ND; Schroers-Martin JG; Liu CL; Oak JS; Jin MC; Beygi S; Hüttmann A; Hanoun C; Dührsen U; Westin JR; Khodadoust MS; Natkunam Y; Majzner RG; Mackall CL; Diehn M; Miklos DB; Alizadeh AA
Cancer Cell; 2023 Jan; 41(1):210-225.e5. PubMed ID: 36584673
[TBL] [Abstract] [Full Text] [Related]
9. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast cancer and High-grade Serous Ovarian cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract] [Full Text] [Related]
10. Contributions of the Women's Health Initiative to Cardiovascular Research: JACC State-of-the-Art Review.
LaMonte MJ; Manson JE; Anderson GL; Baker LD; Bea JW; Eaton CB; Follis S; Hayden KM; Kooperberg C; LaCroix AZ; Limacher MC; Neuhouser ML; Odegaard A; Perez MV; Prentice RL; Reiner AP; Stefanick ML; Van Horn L; Wells GL; Whitsel EA; Rossouw JE;
J Am Coll Cardiol; 2022 Jul; 80(3):256-275. PubMed ID: 35835498
[TBL] [Abstract] [Full Text] [Related]
11. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
12. NeuN, a DNA-binding neuron-specific protein expressed by Merkel cell carcinoma: analysis of 15 cases.
Ungari M; Manotti L; Tanzi G; Varotti E; Ferrero G; Gusolfino MD; Trombatore M; Cavazzuti L; Tolomini M
Pathologica; 2021 Dec; 113(6):421-426. PubMed ID: 34974547
[TBL] [Abstract] [Full Text] [Related]
13. Modeling oral cancer screening in the United States population.
Cramer JD; Grauer J
Oral Oncol; 2022 Jan; 124():105656. PubMed ID: 34864525
[TBL] [Abstract] [Full Text] [Related]
14. Racial and Ethnic Disparities in lung cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract] [Full Text] [Related]
16. Indices of Diet Quality and Risk of lung cancer in the Women's Health Initiative Observational Study.
Myneni AA; Giovino GA; Millen AE; LaMonte MJ; Wactawski-Wende J; Neuhouser ML; Zhao J; Shikany JM; Mu L
J Nutr; 2021 Jun; 151(6):1618-1627. PubMed ID: 33982106
[TBL] [Abstract] [Full Text] [Related]
17. Nutritional epidemiology and the Women's Health Initiative: a review.
Prentice RL; Howard BV; Van Horn L; Neuhouser ML; Anderson GL; Tinker LF; Lampe JW; Raftery D; Pettinger M; Aragaki AK; Thomson CA; Mossavar-Rahmani Y; Stefanick ML; Cauley JA; Rossouw JE; Manson JE; Chlebowski RT
Am J Clin Nutr; 2021 May; 113(5):1083-1092. PubMed ID: 33876183
[TBL] [Abstract] [Full Text] [Related]
18. Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
Koda Y; Kuribayashi K; Doi H; Kitajima K; Nakajima Y; Ishigaki H; Nakamura A; Minami T; Takahashi R; Yokoi T; Kijima T
Oncology; 2021; 99(3):161-168. PubMed ID: 33053560
[TBL] [Abstract] [Full Text] [Related]
19. Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
Qian C; Liu H; Feng Y; Meng S; Wang D; Nie M; Xu M
PLoS One; 2020; 15(8):e0231807. PubMed ID: 32756555
[TBL] [Abstract] [Full Text] [Related]
20. Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.
Tibaldi E; Gnudi F; Panzacchi S; Mandrioli D; Vornoli A; Manservigi M; Sgargi D; Falcioni L; Bua L; Belpoggi F
Acta Histochem; 2020 Jul; 122(5):151548. PubMed ID: 32622430
[TBL] [Abstract] [Full Text] [Related]
[Next]
